Correction to AstraZeneca Story
October 07 2016 - 3:51AM
Dow Jones News
AstraZeneca PLC (AZN.LN) said Friday it has sold its rights
outside the U.S. for nasal spray Rhinocourt Aqua to Johnson &
Johnson (JNJ) affiliate Cilag GmbH International. (In "AstraZeneca
Signs $330 Million Deal with Johnson & Johnson Affiliate," at
0630 GMT, the name of the nasal spray was misspelled in the first
paragraph.)
(END) Dow Jones Newswires
October 07, 2016 03:36 ET (07:36 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2024 to May 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2023 to May 2024